SCHEMBL4039227

SCHEMBL4039227

CNc1cc(CCN(C)C)c2nc(Nc3c(C)cccc3C)c3cncn3c2n1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.47
SRC P12931 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038533 0.72 LCK (0.61) LCK
SCHEMBL4038945 0.69 LCK (0.50) LCK
SCHEMBL4039642 0.67 LCK (0.54) LCKSRC
SCHEMBL4038963 0.67 LCK (0.56) LCKSRC
SCHEMBL4037406 0.66 LCK (0.59) LCK
SCHEMBL4038739 0.66 LCK (0.56) LCKSRC
SCHEMBL4041472 0.66 LCK (0.70) LCKSRC
SCHEMBL4046022 0.66 NOS1 (0.32)
SCHEMBL7969896 0.66 LCK (0.86) LCKSRC
SCHEMBL4036713 0.65 LCK (0.55) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed